Indrayani Biotech (BOM:526445) EV-to-EBIT : 21.05 (As of Jun. 01, 2024)

Indrayani Biotech EV-to-EBIT Chart

Indrayani Biotech Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EV-to-EBIT		Get a 7-Day Free Trial					-59.13	7.60	-3.97	19.45	14.67

Indrayani Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															16.46	14.67	12.58	15.81	16.23

Competitive Comparison of Indrayani Biotech's EV-to-EBIT

For the Specialty Business Services subindustry, Indrayani Biotech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indrayani Biotech's EV-to-EBIT Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Indrayani Biotech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Indrayani Biotech's EV-to-EBIT falls into.

Indrayani Biotech EV-to-EBIT Calculation

Indrayani Biotech's EV-to-EBIT for today is calculated as:

Indrayani Biotech's current Enterprise Value is ₹2,973 Mil.
Indrayani Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹141 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indrayani Biotech  (BOM:526445) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Indrayani Biotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Indrayani Biotech's Enterprise Value for the quarter that ended in Dec. 2023 was ₹2,292 Mil.
Indrayani Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹141 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indrayani Biotech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Indrayani Biotech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Indrayani Biotech (BOM:526445) Business Description